<DOC>
	<DOCNO>NCT02218957</DOCNO>
	<brief_summary>Morbid obesity increase medical problem western country . It 's related comorbidities diabetes mellitus , hypertension , OSAS , arthrosis hypercholesterolemia . The Roux-en-Y Gastric Bypass ( RYGB ) effective surgical therapy morbidly obese patient . A part patient disappointing result , weight regain long term . Some study show weight reduction increase biliopancreatic limb patient morbid obesity . The objective study investigate effect restrictive/extended pouch weight reduction morbidly obese patient undergo RYGB-surgery . We hypothesize restrictive/extended pouch result weight reduction . The study design prospective , randomize control trial . The patient randomize 2 group : standard RYGB ( normal pouch ) restrictive/extended pouch RYGB .</brief_summary>
	<brief_title>Extended Pouch Roux-en-Y Gastric Bypass Study</brief_title>
	<detailed_description />
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Patient eligible bariatric surgery accord Fried guideline Primary Gastric bypass BMI 35 40 comorbidity BMI &gt; 40 Exclusion criterion bariatric surgery ( Fried Guidelines ) Patients language problem interveins follow medical advises Genetic disease intervens follow medical advises Chronic bowel disease Nephrologic ( MDRD &lt; 30 ) liver disease ( AST/ALT twice norm ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Bariatric surgery</keyword>
	<keyword>Roux-en-Y Gastric Bypass</keyword>
</DOC>